Siemens Healthineers eBlast

Web version

Discover how intelligent imaging supports PET/CT for radiation therapy

Join us June 18 at 4:00 pm CET

Data courtesy of Rigshospitalet, Copenhagen, Denmark.

Publications regarding the use of PET imaging in radiation oncology point to the advantages of using PET/CT for staging, radiotherapy planning, and treatment monitoring¹,². Recent reports show that 89% of current RT sites use PET images in some portion of their treatment plans³.

We understand physicians need specialized capabilities to deliver personalized cancer care and radiation treatments. Be the first to learn about our newest innovations and see how we set the standard for PET/CT in RT planning during a free webinar on June 18.

Watch the webinar

¹ Recent advances of PET imaging in clinical radiation oncology - Unterrainer et al. Radiation Oncology (2020) 15:88
² Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial - Lancet Oncol 2020; 21: 581 -92
³ IMV Report 2019
Twitter Icon   Facebook Icon   Instagram Icon   LinkedIn Icon   YouTube Icon
Contact Us | Privacy Policy
This email was sent by:
Siemens Healthcare GmbH | Henkestr. 127, 91052 Erlangen, Germany
Information for healthcare professionals. The Siemens Healthineers newsletter and websites, including but not limited to and its affiliated sites, provide an online resource for healthcare professionals
•  Do not reply to this email as it was sent from an unmonitored account.
•  Unsubscribe from the Molecular Imaging Insider.
•  Reset your password.
• Privacy Policy.
•  Email sent to: ., 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA
+1 520-298-1000